Two Sigma Investments’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$896K Sell
223,913
-84,437
-27% -$338K ﹤0.01% 2265
2025
Q1
$981K Buy
308,350
+278,046
+918% +$884K ﹤0.01% 2136
2024
Q4
$162K Sell
30,304
-41,248
-58% -$221K ﹤0.01% 2836
2024
Q3
$378K Buy
71,552
+23,766
+50% +$125K ﹤0.01% 2521
2024
Q2
$87K Sell
47,786
-54,663
-53% -$99.5K ﹤0.01% 2758
2024
Q1
$182K Sell
102,449
-78,255
-43% -$139K ﹤0.01% 2658
2023
Q4
$318K Sell
180,704
-92,303
-34% -$162K ﹤0.01% 2590
2023
Q3
$399K Buy
273,007
+18,753
+7% +$27.4K ﹤0.01% 2301
2023
Q2
$582K Buy
254,254
+50,207
+25% +$115K ﹤0.01% 2192
2023
Q1
$186K Sell
204,047
-77,140
-27% -$70.2K ﹤0.01% 2499
2022
Q4
$239K Sell
281,187
-148,521
-35% -$126K ﹤0.01% 2274
2022
Q3
$352K Buy
429,708
+68,674
+19% +$56.3K ﹤0.01% 1862
2022
Q2
$357K Sell
361,034
-143,121
-28% -$142K ﹤0.01% 1893
2022
Q1
$827K Sell
504,155
-426,292
-46% -$699K ﹤0.01% 1760
2021
Q4
$2.24M Buy
930,447
+789,992
+562% +$1.9M ﹤0.01% 1277
2021
Q3
$680K Sell
140,455
-169,198
-55% -$819K ﹤0.01% 1877
2021
Q2
$827K Sell
309,653
-39,103
-11% -$104K ﹤0.01% 1765
2021
Q1
$1.07M Buy
+348,756
New +$1.07M ﹤0.01% 1557
2020
Q3
Sell
-50,776
Closed -$138K 1973
2020
Q2
$138K Sell
50,776
-48,482
-49% -$132K ﹤0.01% 1819
2020
Q1
$209K Sell
99,258
-9,341
-9% -$19.7K ﹤0.01% 1590
2019
Q4
$591K Buy
108,599
+44,551
+70% +$242K ﹤0.01% 1628
2019
Q3
$193K Buy
64,048
+17,144
+37% +$51.7K ﹤0.01% 1757
2019
Q2
$175K Sell
46,904
-16,957
-27% -$63.3K ﹤0.01% 1878
2019
Q1
$257K Sell
63,861
-4,839
-7% -$19.5K ﹤0.01% 1870
2018
Q4
$252K Buy
+68,700
New +$252K ﹤0.01% 1810